Summary
Slices of rabbit caudate nucleus were preincubated with 3H-dopamine and then superfused. 3H-dopamine and its metabolites were separated by column chromatography.
The basal outflow of tritium consisted of 68% DOPAC, 21% OMDA metabolites (most of which was HVA), 6% dopamine and 5% MTA. Except for an increase in 3H-dopamine, the basal outflow was little changed by nomifensine or cocaine. Amezinium reduced the outflow of 3H-DOPAC and 3H-OMDA metabolites and increased that of 3H-dopamine and 3H-MTA; its effect was antagonized by nomifensine. Haloperidol 10−7 M selectively enhanced the outflow of 3H-DOPAC and 3H-OMDA metabolites. At haloperidol 10−5M, a large increase in these two fractions was accompanied by a small increase in 3H-dopamine and 3H-MTA. Nomifensine diminished only slightly the outflow of 3H-DOPAC caused by haloperidol.
The overflow of tritium elicited by electrical stimulation at 3 Hz consisted of 74% DOPAC, 15% OMDA metabolites, 10% dopamine and 0.4% MTA. Lowering the frequency reduced the overflow of total tritium and caused a decrease in the percentage of 3H-DOPAC and an increase in the percentage of 3H-dopamine. Nomifensine or cocaine greatly diminished the evoked overflow of 3H-DOPAC and 3H-OMDA compounds and increased the evoked overflow of 3H-dopamine and 3H-MTA. The effects of apomorphine and bromocriptine were similar to those caused by decreasing the stimulation frequency.
The major pathways of the metabolism of previously taken up dopamine, under the conditions of our experiments, are as follows. When the neurones are at rest, dopamine metabolism is initiated by leakage of the amine into the axoplasm, where it is degraded through the aldehyde to DOPAC. Part of the DOPAC is methylated extraneuronally to HVA. Traces of MTA are formed by extraneuronal methylation of dopamine. When action potentials arrive, dopamine metabolism is initiated by exocytosis. The bulk of the extracellular dopamine is taken up back into the neurones. When the stimulation frequency is 3 Hz, most of the axoplasmic dopamine is subsequently transformed to DOPAC; little seems to be re-stored. HVA and MTA are generated essentially as during neuronal rest. When dopamine release is low (stimulation at low frequency; addition of apomorphine or bromocriptine), a larger portion seems to be re-stored, thus leading to a decrease in the percentage of DOPAC. Haloperidol, apart from its receptor blocking properties, acts on dopaminergic axons in a manner akin to the effect of reserpine.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- AD:
-
Aldehyde dehydrogenase (E.C.1.2.1.3.)
- COMT:
-
catechol-O-methyl transferase (E.C 2.1.1.6.)
- DOPAC:
-
3,4-dihydroxyphenylacetic acid
- DOPEG:
-
3,4-dihydroxyphenylglycol
- DOPET:
-
3,4-dihydroxyphenylethanol
- HVA:
-
3-methoxy-4-hydroxyphenylacetic acid
- MAO:
-
monoamine oxidase (E.C. 1.4.3.4.)
- MOPET:
-
3-methoxy-4-hydroxyphenylethanol
- MTA:
-
3-methoxytyramine
- OMDA metabolites:
-
O-methylated and deaminated metabolites. “Intraneuronal” refers to location in dopaminergic terminal axons, “extraneuronal” to location in other cells, neuronal as well as nonneuronal
References
Andén NE, Roos BE, Werdinius B (1963) 3,4-Dihydroxyphenylacetic acid in rabbit corpus striatum normally and after reserpine treatment. Life Sci 5:319–325
Arbilla S, Langer SZ (1980) Influence of monoamine oxidase inhibition on the release of 3H-dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum. Naunyn-Schmiedeberg's Arch Pharmacol 311:45–52
Bönisch H (1980) The rate constants for the efflux of deaminated metabolites of 3H-dopamine from the perfused rat heart. Naunyn-Schmiedeberg's Arch Pharmacol 314:231–235
Borowski E, Starke K, Ehrl H, Endo T (1977) A comparison of pre-and postsynaptic effects of α-adrenolytic drugs in the pulmonary artery of the rabbit. Neuroscience 2:285–296
Carlsson A, Hillarp NA (1962) Formation of phenolic acids in brain after administration of 3,4-dihydroxyphenylalamine. Acta Physiol Scand 55:95–100
Carlsson A, Waldeck B (1964) A method for the fluorimetric determination of 3-methoxytyramine in tissues and the occurrence of this amine in brain. Scand J Clin Lab Investigation 16:133–138
Cubeddu LX, Hoffmann IS, Paris VB (1979a) Effects of papaverine on the release and metabolism of dopamine in rat striatum. J Pharmacol Exp Ther 209:73–78
Cubeddu LX, Hoffmann IS, Ferrari GB (1979b) Metabolism and efflux of [3H]dopamine in rat neostriatum: presynaptic origin of 3,4-[3H]dihydroxyphenylacetic acid. J Pharmacol Exp Ther 209:165–175
Di Chiara G, Balakleevsky A, Proceddu ML, Tagliamonte A, Gessa GL (1974) Inhibition by apomorphine of dopamine deamination in the rat brain. J Neurochem 23:1105–1108
Di Giulio AM, Groppetti A, Cattabeni F, Galli CL, Maggi A, Algeri S, Ponzio F (1978) Significance of dopamine metabolites in the evaluation of drugs acting on dopaminergic neurons. Eur J Pharmacol 52:201–207
Farah MB, Adler-Graschinsky E, Langer SZ (1977) Possible physiological significance of the initial step in the catabolism of noradrenaline in the central nervous system of the rat. Nauny-Schmiedeberg's Arch Pharmacol 297:119–131
Galli CL, Cattabeni F, Eros T, Spano PF, Algeri S, Di Giulio A, Groppetti A (1976) A mass fragmentographic assay of 3-methoxytyramine in rat brain. J Neurochem 27:795–798
Gordon EK, Markey SP, Sherman RL, Kopin IJ (1976) Conjugated 3,4 dihydroxy phenyl acetic acid (DOPAC) in human and monkey cerebrospinal fluid and rat brain and the effects of probenecid treatment. Life Sci 18:1285–1292
Graefe KH, Stefano FJE, Langer SZ (1975) Preferential metabolism of (−)-3H-norepinephrine through the deaminated glycol in the rat vas deferens. Biochem Pharmacol 22:1147–1160
Heikkila RE, Orlansky H, Cohen G (1975) Studies on the distinction between uptake inhibition and release of [3H]dopamine in rat brain tissue slices. Biochem Pharmacol 24:847–852
Hoffmann IS, Cubeddu LX (1978) Metabolism of spontaneous and neurally released 3H-dopamine (DA) from rat neostriatal tissue. In: Abstracts of the 7th International Congress of Pharmacology, p 593
Hunt P, Kannengiesser MH, Raynaud JP (1974) Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum. J Pharm Pharmacol 26:370–371
Jackisch R, Zumstein A, Hertting G, Starke K (1980) Interneurones are probably not involved in the presynaptic dopaminergic control of dopamine release in rabbit caudate nucleus. Naunyn-Schmiedeberg's Arch Pharmacol 314:129–133
Jonason J (1969) Metabolism of catecholamines in the central and peripheral nervous system. Acta Physiol Scand Suppl 320
Jonason J, Rutledge CO (1968) Metabolism of dopamine and noradrenaline in rabbit caudate nucleus in vitro. Acta Physiol Scand 73:411–417
Kaplan GP, Hartman BK, Creveling CR (1979) Immunohistochemical demonstration of catechol-O-methyltransferase in mammalian brain. Brain Res 167:241–250
Kehr W (1976) 3-Methoxytyramine as an indicator of impulse-induced dopamine release in rat brain in vivo. naunyn-Schmiedeberg's Arch Pharmacol 293:209–215
Korf J, Grasdijk L, Westerink BHC (1976) Effects of electrical stimulation of the nigrostriatal pathway of the rat on dopamine metabolism. J Neurochem 26:579–584
Langer SZ (1974) Selective metabolic pathways for noradrenaline in the peripheral and in the central nervous system. Med Biol 52:372–383
Murrin LC, Roth RH (1976) Dopaminergic neurons: reversal of effects elicited by γ-butyrolactone by stimulation of the nigro-neostriatal pathway. Naunyn-Schmiedeberg's Arch Pharmacol 295:15–20
Reimann W, Zumstein A, Jackisch R, Starke K, Hertting G (1979) Effect of extracellular dopamine on the release of dopamine in the rabbit caudate nucleus: evidence for a dopaminergic feedback inhibition. Naunyn-Schmiedeberg's Arch Pharmacol 306:53–60
Roftler-Tarlov S, Sharman DF, Tegerdine P (1971) 3,4-Dihydroxyphenylacetic acid and 4-hydroxy-3-methoxyphenylacetic acid in the mouse striatum: a reflection of intra-and extraneuronal metabolism of dopamine. Br J Pharmacol 42:343–351
Rosengren E (1960) On the role of monoamine oxidase for the inactivation of dopamine in brain. Acta Physiol Scand 49:370–375
Roth RH, Murrin LC, Walters JR (1976) Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid. Eur J Pharmacol 36:163–171
Seeman P, Lee T (1974) The dopamine-releasing actions of neuroleptics and ethanol. J Pharmacol Exp Ther 190:131–140
Sharman DF (1963) A fluorimetric method for the estimation of 4-hydroxy-3-methoxyphenylacetic acid (homovanillic acid) and its identification in brain tissue. Br J Pharmacol 20:204–213
Sharman DF (1973) The catabolism of catecholamines. Br Med Bull 29:110–115
Starke K, Reimann W, Zumstein A, Hertting G (1978) Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 305:27–36
Starke K, Steppeler A, Zumstein A, Henseling M, Trendelenburg U (1980) False labelling of commercially available 3H-catecholamines? Naunyn-Schmiedeberg's Arch Pharmacol 311:109–112
Steppeler A, Starke K (1980) Selective inhibition by amezinium of intraneuronal monoamine oxidase. Naunyn-Schmiedeberg's Arch Pharmacol 314:13–16
Steppeler A, Pfändler R, Hedler L, Starke K (1980) An analysis of the effects of amezinium on postganglionic sympathetic neurones. Naunyn-Schmiedeberg's Arch Pharmacol 314:1–11
Sugden RF, Eccleston D (1971) Glycol sulphate ester formation from [14C]noradrenaline in brain and the influence of a COMT inhibitor J Neurochem 18:2461–2468
Swahn CG, Wiesel FA (1976) Determination of conjugated monoamine metabolites in brain tissue. J Neural Transm 39:281–290
Taube HD, Starke K, Borowski E (1977) Presynaptic receptor systems on the noradrenergic neruones of rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 299:123–141
Tipton KF, Houslay MD, Turner AJ (1977) Metabolism of aldehydes in brain. Essays Neurochem Neuropharmacol 1:103–138
Trendelenburg U, Bönisch H, Graefe KH, Henseling M (1980) The rate constants for the efflux of metabolites of catecholamines and phenethylamines. Pharmacol Rev 31:179–203
Westerink BHC (1979) Further studies on the sequence of dopamine metabolism in the rat brain. Eur J Pharmacol 56:313–322
Westerink BHC, Korf J (1976) Turnover of acid dopamine metabolites in striatal and mesolimbic tissue of the rat brain. Eur J Pharmacol 37:249–255
Westfall TC, Kitay D, Wahl G (1976) The effect of cyclic nucleotides on the release of 3H-dopamine from rat striatal slices. J Pharmacol Exp Ther 199:149–157
Wilk S, Zimmerberg B (1973) Absence of 3-methoxy-4-hydroxyphenylethanol in brain. Biochem Pharmacol 22:623–628
Zumstein A, Karduck W, Starke K (1979) Metabolism of dopamine in rabbit caudate nucleus in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 308:R15
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zumstein, A., Karduck, W. & Starke, K. Pathways of dopamine metabolism in the rabbit caudate nucleus in vitro. Naunyn-Schmiedeberg's Arch. Pharmacol. 316, 205–217 (1981). https://doi.org/10.1007/BF00505651
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00505651